Compare Davita Inc (DVA) vs TJX Companies Inc (TJX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs TJX Companies Inc — how do they compare? Davita Inc trades at $178.24 (market cap $11.29B), while TJX Companies Inc trades at $138.68 (market cap $152.62B). The key difference: TJX Companies Inc is far larger — about 13.5× Davita Inc's market cap, and TJX Companies Inc pays a 1.38% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and TJX Companies Inc for 97 Days on average.
| DVA | TJX | |
|---|---|---|
Market Cap | $11.29B | $152.62B |
Volume | 582,204 | 8,079,794 |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $168.41 |
52-Week Low | $103.87 | $122.84 |
Typical Hold Time | 113 Days | 97 Days |
Enterprise Value | $24.01B | $160.93B |
Dividend Yield | — | 1.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
TJX trades at $138.80, up 1.28% today, with a bullish technical trend and strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.33. Revenue grew to $56.36B in 2025, with a net income margin of 8.63%. Analysts are overwhelmingly bullish, with an 84.9% buy rating and a consensus price target of $174.15, implying 25% upside. Recent news highlights TJX's value proposition and merchandising strength in the off-price retail sector.
TJX presents a compelling investment opportunity driven by earnings growth, high profitability (ROE 62.17%), and positive analyst sentiment. Risks include competitive pressures, economic sensitivity, and valuation multiples above industry averages. The stock's momentum and fundamental strength support a favorable outlook, but investors should monitor execution against future earnings expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →
